Serum prostate-specific antigen levels in men with type 2 diabetes

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 930-931

  Fukui, Mlchiaki ^a   Tanaka, Muhei ^a   Kadono, Mayuko ^a   Imai, Saeko ^b   Hasegawa, Goji ^a   Yoshikawa, Toshikazu ^a   Nakamura, Naoto ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; INSULIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TRIACYLGLYCEROL; ANDROGEN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; MIDDLE AGED; REFERENCE VALUE;

ADULT; AGED; ANDROGENS; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; REFERENCE VALUES;

EID: 48649095772     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1962     Document Type: Article

References (9)

1. Everhart J, Wright D: Diabetes mellitus as a risk factor for pancreatic cancer: a metaanalysis. JAMA 273:1605-1609, 1995
2. Stricker HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD, Yu H: the relation of type 2 diabetes and cancer. Diabetes Technol Ther 3:263-274, 2001
3. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO: Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102:258-261, 2002
4. Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE: Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 161: 147-152, 2005
5. Bonovas S, Filioussi K, Tsantes A: Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47:1071-1078, 2004
6. Andersson B, Marin P, Lissner L, Ver-meulen A, Bjorntorp P: Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405-411, 1994
7. Shaneyfelt T, Husein R, Bubley G, Mant- zoros CS: Hormonal predictors of prostate cancer: a meta-analysis. J Clin Oncol 18:847-853, 2000
8. Monath JR, McCullough DL, Hart LJ, Jarow JP: Physiologic variations of serum testosterone within the normal range do not affect serum prostate-specific antigen. Urology 46:58-61, 1995
9. Velicer CM, Dublin S, White E: Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications. Prostate Cancer Prostatic Dis 10:46-51, 2007